Trials / Completed
CompletedNCT03204630
Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 236 (actual)
- Sponsor
- Biosearch S.A. · Industry
- Sex
- All
- Age
- 3 Weeks – 5 Weeks
- Healthy volunteers
- Accepted
Summary
A randomized double blinded controlled study including infants at the age of 1 month . Infants are assigned randomly to either infant formula supplemented with B. breve CECT7263 or L.fermentum CECT5716 (Probiotic groups), or the same formula without the probiotic strain (Control group). The primary outcome of the study is the body weight gain of infants. Secondary outcomes are incidence of infections, symptoms related with intestinal function, and fecal microbiota
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lfer | Probiotic bacteria originally isolated from breast milk: the strain Lactobacillus fermentum CECT5716 |
| DIETARY_SUPPLEMENT | Bifido | Probiotic bacteria originally isolated from breast milk: the strain Bifidobacterium breve CECT7263 |
| OTHER | Control | Standard infant formula |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2014-11-01
- Completion
- 2015-12-01
- First posted
- 2017-07-02
- Last updated
- 2017-07-02
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03204630. Inclusion in this directory is not an endorsement.